Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 9, Number 11—November 2003
Dispatch

Fluoroquinolone Resistance Linked to GyrA, GyrB, and ParC Mutations in Salmonella enterica Typhimurium Isolates in Humans

Isabelle Casin*†, Jacques Breuil†‡, Jean Pierre Darchis§, Claire Guelpa¶, and Ekkehard Collatz†Comments to Author 
Author affiliations: *Hôpital Saint-Louis, Université Paris VII, Paris, France; †INSERM E0004-LRMA, Université Paris VI, Paris, France; ‡Centre Hospitalier Villeneuve-Saint Georges, Villeneuve-Saint Georges, France; §Centre Hospitalier de Compiègne, Compiègne, France; ¶Hôpital du Val d’Yerres, Yerres, France

Main Article

Table

Antimicrobial drug susceptibilities of the Salmonella enterica Typhimurium isolates

Isolate MIC (mg/L)a
NOR CIPb CTM CTX
NCTC
12416
 0.06
 0.016
 0.06
 0.125
A
 32
 16
 0.06
 0.06
B1
 32
 32
 0.25
 0.125
B2
 32
 32
 1
 0.25
B3
 32
 32
 1
 0.25
C 32 32 0.25 0.125

aNOR, norfloxacin; CIP, ciprofloxacin; CTM, cefotaxime; CTX, ceftriaxone.
bMICs of moxifloxacin were identical to those of CIP.

Main Article

Page created: January 21, 2011
Page updated: January 21, 2011
Page reviewed: January 21, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external